1.
Bone Marrow Transplant
; 50 Suppl 2: S51-4, 2015 Jun.
Article
in English
| MEDLINE
| ID: mdl-26039208
ABSTRACT
Allogenic stem cell transplantation (allo-SCT) represents the only curative option for several hematological malignancies. Due to a delayed and dysfunctional immunological recovery infectious complications and residual tumor cells following allo-SCT are still major causes of failure of this procedure. Here we discuss the most common infectious complications of allo-SCT and describe current and future strategies to prophylaxe or treat these complications using novel immunotherapeutic strategies.